3/2
09:27 am
cbio
Crescent Biopharma (CBIO) had its price target lowered by HC Wainwright from $25.00 to $22.00. They now have a "buy" rating on the stock.
Low
Report
Crescent Biopharma (CBIO) had its price target lowered by HC Wainwright from $25.00 to $22.00. They now have a "buy" rating on the stock.
2/26
07:00 pm
cbio
Crescent Biopharma (CBIO) was given a new $29.00 price target by Stifel Nicolaus.
Low
Report
Crescent Biopharma (CBIO) was given a new $29.00 price target by Stifel Nicolaus.
1/29
07:41 am
cbio
Crescent Biopharma (NASDAQ:CBIO) was upgraded by analysts at Piper Sandler to a "strong-buy" rating.
Medium
Report
Crescent Biopharma (NASDAQ:CBIO) was upgraded by analysts at Piper Sandler to a "strong-buy" rating.
1/28
07:03 am
cbio
Crescent Biopharma (NASDAQ:CBIO) is now covered by analysts at Piper Sandler. They set an "overweight" rating on the stock.
High
Report
Crescent Biopharma (NASDAQ:CBIO) is now covered by analysts at Piper Sandler. They set an "overweight" rating on the stock.
1/24
12:30 am
cbio
Crescent Biopharma (NASDAQ:CBIO) was upgraded by analysts at
Wall Street
Medium
Report
Crescent Biopharma (NASDAQ:CBIO) was upgraded by analysts at
Wall Street
1/22
07:48 am
cbio
Crescent Biopharma (NASDAQ:CBIO) was upgraded by analysts at Guggenheim to a "strong-buy" rating.
Low
Report
Crescent Biopharma (NASDAQ:CBIO) was upgraded by analysts at Guggenheim to a "strong-buy" rating.
1/21
07:17 am
cbio
Crescent Biopharma (NASDAQ:CBIO) is now covered by analysts at Guggenheim. They set a "buy" rating on the stock.
Low
Report
Crescent Biopharma (NASDAQ:CBIO) is now covered by analysts at Guggenheim. They set a "buy" rating on the stock.